Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
Translational Neurodegeneration
|
November 16, 2023
A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease
Alireza Faridar, Abdulmunaim M Eid, Aaron D Thome, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
January 9, 2018
An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis
Christina N Fournier, David Schoenfeld, James D Berry, et al.
Toxicology
|
September 1, 2004
Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signals
Seong-Ho Koh, Hyugsung Kwon, Kyung Suk Kim, et al.
Plos Medicine
|
October 31, 2024
Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial
Steven Perrin, Shafeeq Ladha, Nicholas Maragakis, et al.
Scientific Reports
|
March 29, 2019
Human Bone Marrow Endothelial Progenitor Cell Transplantation into Symptomatic ALS Mice Delays Disease Progression and Increases Motor Neuron Survival by Repairing Blood-Spinal Cord Barrier
Svitlana Garbuzova-Davis, Crupa Kurien, Edward Haller, et al.
JAMA Neurology
|
April 25, 2017
Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes
Weihua Zhao, David R Beers, Kristopher G Hooten, et al.
JAMA Neurology
|
February 19, 2014
TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis
Janet Cady, Erica D Koval, Bruno A Benitez, et al.
Acta Neuropathologica Communications
|
September 30, 2022
Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's disease
Alireza Faridar, Matthew Vasquez, Aaron D Thome, et al.
Annals of Neurology
|
May 9, 2017
Pyrimethamine significantly lowers cerebrospinal fluid Cu/Zn superoxide dismutase in amyotrophic lateral sclerosis patients with SOD1 mutations
Dale J Lange, Mona Shahbazi, Vincenzo Silani, et al.
Brain : a Journal of Neurology
|
April 7, 2021
Neuroinflammation is highest in areas of disease progression in semantic dementia
Belen Pascual, Quentin Funk, Paolo Zanotti-Fregonara, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
Translational Neurodegeneration
|
November 16, 2023
A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease
Alireza Faridar, Abdulmunaim M Eid, Aaron D Thome, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
January 9, 2018
An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis
Christina N Fournier, David Schoenfeld, James D Berry, et al.
Toxicology
|
September 1, 2004
Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signals
Seong-Ho Koh, Hyugsung Kwon, Kyung Suk Kim, et al.
Plos Medicine
|
October 31, 2024
Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial
Steven Perrin, Shafeeq Ladha, Nicholas Maragakis, et al.
Scientific Reports
|
March 29, 2019
Human Bone Marrow Endothelial Progenitor Cell Transplantation into Symptomatic ALS Mice Delays Disease Progression and Increases Motor Neuron Survival by Repairing Blood-Spinal Cord Barrier
Svitlana Garbuzova-Davis, Crupa Kurien, Edward Haller, et al.
JAMA Neurology
|
April 25, 2017
Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes
Weihua Zhao, David R Beers, Kristopher G Hooten, et al.
JAMA Neurology
|
February 19, 2014
TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis
Janet Cady, Erica D Koval, Bruno A Benitez, et al.
Acta Neuropathologica Communications
|
September 30, 2022
Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's disease
Alireza Faridar, Matthew Vasquez, Aaron D Thome, et al.
Annals of Neurology
|
May 9, 2017
Pyrimethamine significantly lowers cerebrospinal fluid Cu/Zn superoxide dismutase in amyotrophic lateral sclerosis patients with SOD1 mutations
Dale J Lange, Mona Shahbazi, Vincenzo Silani, et al.
Brain : a Journal of Neurology
|
April 7, 2021
Neuroinflammation is highest in areas of disease progression in semantic dementia
Belen Pascual, Quentin Funk, Paolo Zanotti-Fregonara, et al.
Page
of 10